The value of NT-proBNP in Cardiovascular Risk Stratification and Optimization of Cardioprotective Treatment among Patients with Type 2 Diabetes.
29 August 2021 (14:00 - 14:10)
Organised by:
About the speakers
Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)
University Hospital Germans Trias and Pujol de Badalona, Badalona (Spain)
1 More presentation in this session
Access the full session
The Event
ESC Congress 2021 - The Digital Experience
29 August 2021
14:00 CET
You may be interested in
Congress Session
Congress Session
